Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma.

Abstract

Ruthenium-106 plaque radiotherapy is an effective treatment for primary malignant iris melanoma, resulting in excellent local control with preservation of vision.

Main complications included cataract, dry eyes, and glaucoma.

Full Text

DOI - (DOI)
Swets Information Services - full-text online
Nature Publishing Group - full-text online
EBSCO - full-text online

Subjects

Similar articles

Scleral Necrosis after Plaque Radiotherapy of Uveal Melanoma: A Case-Control Study. (2013-01-21)
[Chorioretinal scarring after radiotherapy of malignant choroidal melanoma with the ruthenium 106 applicator] (1984-04-06)
Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. (2002-10-02)
Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. (2001-10-04)
Radiotherapy for ocular tumours. (2012-11-23)
Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies. (1994-02-10)
Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience. (2003-11-11)
Local tumor control after 106Ru brachytherapy of choroidal melanoma. (2005-09-19)
A modified COMS plaque for iris melanoma. (2011-09-30)

Authors

Publication date

2011-12-13

Journal

Eye
Eye (Lond) (1476-5454)

Journal topics

Language

Eng.

Copyright

Department of Ophthalmology, St Bartholomew's Hospital and Moorfields Eye Hospital, London, UK. maria.tsimpida [at] bartsandthelondon.nhs.uk

Release reference

Eye (Lond). 2011 Dec;25(12):1607-11

Related books

Español | English

© Galenicom 1999-2013